Abstract
As regulations on serum importation stagnate, the industry moves toward treatment options
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
APHIS. 1994. Importation of fetal bovine serum. Federal Register 59: (38) 9142–9146.
Hodgson, J. 1993. Fetal bovine serum revisited. Bio/Technology 11: 49–53.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgson, J. To Treat or Not to Treat: That Is the Question for Serum. Nat Biotechnol 13, 334–337 (1995). https://doi.org/10.1038/nbt0495-333
Issue Date:
DOI: https://doi.org/10.1038/nbt0495-333
This article is cited by
-
A plea to reduce or replace fetal bovine serum in cell culture media
Cytotechnology (2013)